NCT06221072 2024-01-24
A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid
Shanghai JMT-Bio Inc.
Phase 3 Not yet recruiting
Clinical Trials
1 trialsPhase 3 × INDUSTRY × Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors × Clear all